Management of Endocrine Tumors, An Issue of Surgical Oncology Clinics of North America

A Contemporary Review of the Treatment of Medullary Thyroid Carcinoma in the Era of New Drug Therapies<br>A Nomogram for Relapse/Death and Contemplating Adjuvant Therapy for Parathyroid Carcinoma<br>Parathyroid Cancer: Updates and Postoperative Surveillance Imaging<br>Adrenocortical Carcinoma: Role of Adjuvant and Neoadjuvant Therapy<br>Succinate Dehydrogenase Mutations as Familial Pheochromocytoma Syndromes<br>Genetic Testing for Adrenal Tumors—What the Contemporary Surgeon Should Know<br>Multiple Endocrine Neoplasia Type 1 Syndrome Pancreatic Neuroendocrine Tumor Genotype/Phenotype: Is There Any Advance on Predicting or Preventing?<br>Minimally Invasive Pancreatectomy: Robotic and Laparoscopic Developments<br>Status of Surveillance and Nonsurgical Therapy for Small Nonfunctioning Pancreatic Neuroendocrine Tumors<br>Lobectomy or Total Thyroidectomy—Where Is the Pendulum now for Differentiated Thyroid Cancer?<br>A Nod to the Nodes: An Overview of the Role of Central Neck Dissection in the Management of Papillary Thyroid Carcinoma